Patents by Inventor Marc J. Tolkoff

Marc J. Tolkoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5607407
    Abstract: The present invention relates to catheters for use with subcutaneous access ports for continuous or intermittent infusion therapy. These catheters utilize a pretensioned, helical coil which is incorporated into a flexible cannulated portion. This feature allows the flexible cannula to be bent without kinking under normal use. This flexibility provides a great deal of comfort to the patient. These catheters also incorporate a puncture needle which is positioned axially down the length of the catheter such that the sharp point at the distal end of the needle extends beyond the distal end of the catheter. This combination of a pretensioned, flexible catheter and a puncture needle achieves a stiffness sufficient to penetrate the tough, self-sealing septum used in subcutaneous access ports, yet, once the puncture needle is removed the patient is left with a comfortable alternative to commonly used hypodermic needles.
    Type: Grant
    Filed: August 14, 1995
    Date of Patent: March 4, 1997
    Inventors: Marc J. Tolkoff, Fernando A. de Toledo
  • Patent number: 4969470
    Abstract: The coronary sinus is intermittently occluded by use of means for occluding the sinus, a pressure transducer for sensing the fluid pressure within the sinus and providing corresponding fluid pressure signals, and a controller responsive to the transducer and arranged to provide trigger signals to the occluding means to trigger an occlusion and to interrupt the occlusion, the system being characterized in that the controller is arranged to estimate a plateau level of the fluid pressure during each occlusion and for providing a trigger signal to interrupt each occlusion on the basis of the estimate. The duration of the interruption before the next occlusion is controlled in response to the volume flow in the sinus during the interruption. Pharmacological agents are injected into the sinus during the occlusion, for retroperfusion to the heart tissue. An analysis of heart function is obtained by analyzing the local pressure maxima in successive heartbeats during occlusion.
    Type: Grant
    Filed: October 4, 1989
    Date of Patent: November 13, 1990
    Assignee: Boston Scientific Corporation
    Inventors: Werner Mohl, Marc J. Tolkoff
  • Patent number: 4934996
    Abstract: The coronary sinus is intermittently occluded by use of means for occluding the sinus, a pressure transducer for sensing the fluid pressure within the sinus and providing corresponding fluid pressure signals, and a controller responsive to the transducer and arranged to provide trigger signals to the occluding means to trigger an occlusion and to interrupt the occlusion, the system being characterized in that the controller is arranged to estimate a plateau level of the fluid pressure during each occlusion and for providing a trigger signal to interrupt each occlusion on the basis of the estimate. The duration of the interruption before the next occlusion is controlled in response to the volume flow in the sinus during the interruption. Pharmacological agents are injected into the sinus during the occlusion, for retroprofusion to the heart tissue. An analysis of heart function is obtained by analyzing the local pressure maxima in successive heartbeats during occlusion.
    Type: Grant
    Filed: January 31, 1986
    Date of Patent: June 19, 1990
    Assignee: Boston Scientific Corporation
    Inventors: Werner Mohl, Marc J. Tolkoff
  • Patent number: 4887608
    Abstract: The coronary sinus is intermittently occluded by use of means for occluding the sinus, a pressure transducer for sensing the fluid pressure within the sinus and providing corresponding fluid pressure signals, and a controller responsive to the transducer and arranged to provide trigger signals to the occluding means to trigger an occlusion and to interrupt the occlusion, the system being characterized in that the controller is arranged to estimate a plateau level of the fluid pressure during each occlusion and for providing a trigger signal to interrupt each occlusion on the basis of the estimate. The duration of the interruption before the next occlusion is controlled in response to the volume flow in the sinus during the interruption. Pharmacological agents are injected into the sinus during the occlusion, for retroprofusion to the heart tissue. An analysis of heart function is obtained by analyzing the local pressure maxima in successive heartbeats during occlusion.
    Type: Grant
    Filed: January 10, 1989
    Date of Patent: December 19, 1989
    Assignee: Boston Scientific Corporation
    Inventors: Werner Mohl, Marc J. Tolkoff
  • Patent number: 4705040
    Abstract: For percutaneous fixation of a hollow organ of a body, a hollow needle carrying a retaining device attached to a tension filament through the skin into the hollow organ, the retaining device is released from the needle, and the organ is fixed by adjusting the tension on the filament and clamping the filament outside the body by means bearing upon the exterior of the body.
    Type: Grant
    Filed: November 18, 1985
    Date of Patent: November 10, 1987
    Assignee: Medi-Tech, Incorporated
    Inventors: Peter R. Mueller, Alan S. Brown, Marc J. Tolkoff, Frank B. Crawford
  • Patent number: 4654036
    Abstract: An elongated rod-shaped medical device has a weighted portion of greater density than adjacent portions thereof for providing useful weight in light medical devices. The weighted portion has a plurality of interfitting metallic weights with facing, engaging sliding surfaces to provide for high specific gravity and high bulk density in a yieldable small diameter device.
    Type: Grant
    Filed: January 16, 1986
    Date of Patent: March 31, 1987
    Assignee: Norwich-Eaton Pharmaceuticals, Inc.
    Inventor: Marc J. Tolkoff
  • Patent number: RE34021
    Abstract: For percutaneous fixation of a hollow organ of a body, a hollow needle carrying a retaining device attached to a tension filament through the skin into the hollow organ, the retaining device is released from the needle, and the organ is fixed by adjusting the tension on the filament and clamping the filament outside the body by means bearing upon the exterior of the body.
    Type: Grant
    Filed: November 13, 1989
    Date of Patent: August 4, 1992
    Assignee: Abbott Laboratories
    Inventors: Peter R. Mueller, Alan S. Brown, Marc J. Tolkoff, Frank B. Crawford